140 related articles for article (PubMed ID: 9335562)
1. Miscoding potential of tamoxifen-derived DNA adducts: alpha-(N2-deoxyguanosinyl)tamoxifen.
Shibutani S; Dasaradhi L
Biochemistry; 1997 Oct; 36(42):13010-7. PubMed ID: 9335562
[TBL] [Abstract][Full Text] [Related]
2. Miscoding properties of model estrogen-DNA adducts in reactions catalyzed by mammalian and Escherichia coli DNA polymerases.
Shibutani S; Itoh S; Yoshizawa I
Biochemistry; 1997 Feb; 36(7):1755-65. PubMed ID: 9048559
[TBL] [Abstract][Full Text] [Related]
3. Translesional synthesis on DNA templates containing an estrogen quinone-derived adduct: N2-(2-hydroxyestron-6-yl)-2'-deoxyguanosine and N6-(2-hydroxyestron-6-yl)-2'-deoxyadenosine.
Terashima I; Suzuki N; Dasaradhi L; Tan CK; Downey KM; Shibutani S
Biochemistry; 1998 Sep; 37(39):13807-15. PubMed ID: 9753470
[TBL] [Abstract][Full Text] [Related]
4. Miscoding properties of 3,N4-etheno-2'-deoxycytidine in reactions catalyzed by mammalian DNA polymerases.
Shibutani S; Suzuki N; Matsumoto Y; Grollman AP
Biochemistry; 1996 Nov; 35(47):14992-8. PubMed ID: 8942665
[TBL] [Abstract][Full Text] [Related]
5. Miscoding events during DNA synthesis past the nitration-damaged base 8-nitroguanine.
Suzuki N; Yasui M; Geacintov NE; Shafirovich V; Shibutani S
Biochemistry; 2005 Jun; 44(25):9238-45. PubMed ID: 15966748
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen.
Terashima I; Suzuki N; Shibutani S
Cancer Res; 1999 May; 59(9):2091-5. PubMed ID: 10232593
[TBL] [Abstract][Full Text] [Related]
7. Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa.
Yasui M; Suzuki N; Laxmi YR; Shibutani S
Biochemistry; 2006 Oct; 45(39):12167-74. PubMed ID: 17002316
[TBL] [Abstract][Full Text] [Related]
8. Miscoding properties of 6alpha- and 6beta-diastereoisomers of the N(2)-(estradiol-6-yl)-2'-deoxyguanosine DNA adduct by Y-family human DNA polymerases.
Poon K; Itoh S; Suzuki N; Laxmi YR; Yoshizawa I; Shibutani S
Biochemistry; 2008 Jun; 47(25):6695-701. PubMed ID: 18512958
[TBL] [Abstract][Full Text] [Related]
9. Mutagenic properties of 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene, a persistent acetylaminofluorene-derived DNA adduct in mammalian cells.
Yasui M; Dong H; Bonala RR; Suzuki N; Ohmori H; Hanaoka F; Johnson F; Grollman AP; Shibutani S
Biochemistry; 2004 Nov; 43(47):15005-13. PubMed ID: 15554708
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and miscoding specificity of oligodeoxynucleotide containing 8-phenyl-2'-deoxyguanosine.
Kohda K; Tsunomoto H; Kasamatsu T; Sawamura F; Terashima I; Shibutani S
Chem Res Toxicol; 1997 Dec; 10(12):1351-8. PubMed ID: 9437525
[TBL] [Abstract][Full Text] [Related]
11. Translesion synthesis past estrogen-derived DNA adducts by human DNA polymerases eta and kappa.
Suzuki N; Itoh S; Poon K; Masutani C; Hanaoka F; Ohmori H; Yoshizawa I; Shibutani S
Biochemistry; 2004 May; 43(20):6304-11. PubMed ID: 15147214
[TBL] [Abstract][Full Text] [Related]
12. Translesion synthesis past 2'-deoxyxanthosine, a nitric oxide-derived DNA adduct, by mammalian DNA polymerases.
Yasui M; Suzuki N; Miller H; Matsuda T; Matsui S; Shibutani S
J Mol Biol; 2004 Nov; 344(3):665-74. PubMed ID: 15533436
[TBL] [Abstract][Full Text] [Related]
13. Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa.
Suzuki N; Yasui M; Santosh Laxmi YR; Ohmori H; Hanaoka F; Shibutani S
Biochemistry; 2004 Sep; 43(35):11312-20. PubMed ID: 15366941
[TBL] [Abstract][Full Text] [Related]
14. Miscoding properties of 2'-deoxyinosine, a nitric oxide-derived DNA Adduct, during translesion synthesis catalyzed by human DNA polymerases.
Yasui M; Suenaga E; Koyama N; Masutani C; Hanaoka F; Gruz P; Shibutani S; Nohmi T; Hayashi M; Honma M
J Mol Biol; 2008 Apr; 377(4):1015-23. PubMed ID: 18304575
[TBL] [Abstract][Full Text] [Related]
15. Translesional synthesis past acetylaminofluorene-derived DNA adducts catalyzed by human DNA polymerase kappa and Escherichia coli DNA polymerase IV.
Suzuki N; Ohashi E; Hayashi K; Ohmori H; Grollman AP; Shibutani S
Biochemistry; 2001 Dec; 40(50):15176-83. PubMed ID: 11735400
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic specificity of (acetylamino)fluorene-derived DNA adducts in mammalian cells.
Shibutani S; Suzuki N; Grollman AP
Biochemistry; 1998 Sep; 37(35):12034-41. PubMed ID: 9724514
[TBL] [Abstract][Full Text] [Related]
17. Mutational specificities of brominated DNA adducts catalyzed by human DNA polymerases.
Sassa A; Ohta T; Nohmi T; Honma M; Yasui M
J Mol Biol; 2011 Mar; 406(5):679-86. PubMed ID: 21241706
[TBL] [Abstract][Full Text] [Related]
18. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
[TBL] [Abstract][Full Text] [Related]
19. Miscoding properties of 8-chloro-2'-deoxyguanosine, a hypochlorous acid-induced DNA adduct, catalysed by human DNA polymerases.
Sassa A; Kamoshita N; Matsuda T; Ishii Y; Kuraoka I; Nohmi T; Ohta T; Honma M; Yasui M
Mutagenesis; 2013 Jan; 28(1):81-8. PubMed ID: 23076070
[TBL] [Abstract][Full Text] [Related]
20. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
Dasaradhi L; Shibutani S
Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
